NX Ireland achieves GDP certification for captive warehouse

Nippon Express (Ireland) Ltd, a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution Practice (GDP) certification from the Irish Exporters Association (IEA), effective September 21, for the temporary storage and air/ocean forwarding of pharmaceutical products at its warehouse near Dublin International Airport.

As one of the world's leading manufacturers and exporters of pharmaceutical products as well as home to the National Institute for Bioprocessing Research and Training (NIBRT), Ireland has attracted a broad range of life science companies. All the world's top 10 pharmaceutical companies have set up operations in Ireland, and the country is expected to continue seeing growth in businesses related to pharmaceuticals. 

The recently GDP-certified NX Ireland Contract Logistics Center is located approximately 3 km from Dublin International Airport and 12 km from Dublin Port, making it an ideal site for both air and sea transport. The facility is equipped with a temperature-controlled facility (2,509 m2) that can accommodate two temperature ranges -- refrigerated storage from 2 C to 8 C and constant-temperature storage from 15 C to 25 C -- and provides a safe and high-quality pharmaceutical logistics platform by combining the NX Group's international temperature-controlled transport services with temporary storage capabilities in a GDP-certified warehouse.

The NX Group will continue strengthening its efforts in the pharmaceutical industry, which is positioned as a priority industry in the Group's current business plan, as well as expanding and developing its services globally to meet increasingly sophisticated and diverse pharmaceutical logistics needs.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!